Special Issue "Combination and Innovative Therapies for Pancreatic Cancer"
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 21261
Interests: pancreatic cancer; surgery; neoadjuvant; immunotherapy; virotherapy; biomarkers; personalized medicine; chemo sensitivity
The incidence of pancreatic cancer is still increasing worldwide, but unfortunately the prognosis remains dismal for most patients. Although some progression has been made recently with new chemotherapeutic regimens, especially for patients with resectable disease, new approaches to attack this aggressive disease are desperately needed. Among other new targeted therapies, immunotherapy, oncolytic virotherapy, and new locoregional therapies, applied either alone or in combination with existing therapies, are being investigated for use in metastatic, locally advanced, or resectable pancreatic cancer patients.
This Special Issue of Cancers will include basic, translational and clinical studies focusing on new combination and innovative therapies in pancreatic cancer. Our aim is to aid in the development of new strategies to treat this complex disease.
Prof. Dr. Casper H.J. van Eijck
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pancreatic cancer
- targeted therapy
- locoregional therapy
- combination therapy